Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2-Reference-Cited by-同舟云学术

Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2

Published:2020-12-13 Issue:1 Volume:61 Page:125-136
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Diener Hans‐Christoph¹,Marmura Michael J.²,Tepper Stewart J.³,Cowan Robert⁴,Starling Amaal J.⁵,Diamond Merle L.⁶,Hirman Joe⁷,Mehta Lahar⁸,Brevig Thomas⁹,Sperling Bjørn⁹,Cady Roger⁸

Affiliation:

1. Institute for Medical Informatics, Biometry and Epidemiology Medical Faculty of the University of Duisburg‐Essen Essen Germany

2. Jefferson Headache Center Thomas Jefferson University Hospitals Philadelphia PA USA

3. Department of Neurology Geisel School of Medicine at Dartmouth Hanover NH USA

4. Department of Neurology and Neurological Sciences Stanford University Headache and Facial Pain Program Palo Alto CA USA

5. Department of Neurology Mayo Clinic Scottsdale AZ USA

6. Diamond Headache Clinic Chicago IL USA

7. Pacific Northwest Statistical Consulting, Inc. Woodinville WA USA

8. Lundbeck Seattle BioPharmaceuticals, Inc. Bothell WA USA

9. H. Lundbeck A/S Copenhagen Denmark

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/head.14036

Reference31 articles.

1. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study

2. Pathophysiology, prevention, and treatment of medication overuse headache

3. Chronic Daily Headache and Medication Overuse Headache in First-Visit Headache Patients in Korea: A Multicenter Clinic-Based Study

4. Clinical and Demographical Characteristics of Patients with Medication Overuse Headache in Argentina and Chile: Analysis of the Latin American Section of COMOESTAS Project

5. Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication-Overuse Headache: Update on Management;Life;2024-09-11

2. Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons—A Comprehensive Review;International Journal of Molecular Sciences;2024-09-07

3. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine;Cephalalgia;2024-09

4. Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache;Headache: The Journal of Head and Face Pain;2024-06-24

5. Medication-overuse headache: a narrative review;The Journal of Headache and Pain;2024-05-31